Robert P. Baughman

Jan 18, 2024 | chestmed.theclinics.com | Robert P. Baughman |Elyse E. Lower |Marc A. Judson

This site can’t provide a secure connection acw.secure.jbs.elsevierhealth.com uses an unsupported protocol.

Dec 6, 2023 | chestmed.theclinics.com | Robert P. Baughman |Marc A. Judson

Sarcoidosis is one of the most common idiopathic interstitial lung diseases treated by health care providers. While it affects the lungs in over 90% of cases, it can affect any part of the body. The multiorgan involvement of sarcoidosis impacts the approach to both diagnosis and treatment. This issue of Clinics of Chest Medicine contains several articles concerning pulmonary aspects of the disease.

Sep 7, 2023 | respiratory-research.biomedcentral.com | Ying Zhou |Mengmeng Zhao |Elyse E. Lower |Robert P. Baughman |Xianqiu Chen

ReferencesRossides M, Darlington P, Kullberg S, Arkema EV, Sarcoidosis. Epidemiology and clinical insights. J INTERN MED [Journal Article; Review]. 2023 2023-06-01;293(6):668–80. Ying Z, Elyse EL, Yinping F, Shanshan D, Huiping L, Robert PB. Clinical characteristics of sarcoidosis patients in the United States versus China. Sarcoidosis Vasc Diffuse Lung Dis [Journal Article]. 2017 2017-01-20;34(3):209–16. Belperio JA, Shaikh F, Abtin FG, Fishbein MC, Weigt SS, Saggar R et al.

May 24, 2023 | thelancet.com | Roberto G. Carbone |Elyse E. Lower |Robert P. Baughman |Francesco Puppo

Vivienne Kahlmann and colleagues1Kahlmann V Moor CC van Helmondt SJ et al. Online mindfulness-based cognitive therapy for fatigue in patients with sarcoidosis (TIRED): a randomised controlled trial. did a randomised controlled trial to assess the effect of a 12-week online mindfulness-based cognitive therapy (eMBCT) on fatigue in sarcoidosis. Kahlmann and colleagues1Kahlmann V Moor CC van Helmondt SJ et al.

May 23, 2023 | thelancet.com | Robert P. Baughman